Malin Corporation plc
ISE:MLC.IR
5.8 (EUR) • At close October 31, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Malin Corporation plc |
Symbool | MLC.IR |
Munteenheid | EUR |
Prijs | 5.8 |
Beurswaarde | 109,557,940 |
Dividendpercentage | 0% |
52-weken bereik | 3.84 - 6.45 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Darragh Fergal Lyons |
Website | https://malinplc.com |
An error occurred while fetching data.
Over Malin Corporation plc
Malin Corporation plc, through its subsidiaries, operates in the life sciences industry in Ireland and the United States. It offers life-saving cell and gene therapies for patients with high unmet medical need; medicines to address unmet needs in cancer, infection, and autoimmune diseases; and treatment of recurrent vulvovaginal candidiasis, an
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (EUR)
Cijfers zijn in miljoenen (EUR)